Latest Articles
Body fat percentage associated with endometriosis severity in cross-sectional analysis - Contemporary OB/GYN
Body fat percentage associated with endometriosis severity in cross-sectional analysis Contemporary OB/GYN
Published: Feb. 18, 2026, 8:38 p.m.
Savannah Chamber presents Business Awards - WTOC
Savannah Chamber presents Business Awards WTOC
Published: Feb. 18, 2026, 6:51 p.m.
Doctor addresses endometriosis myths and treatment options - WTOC
Doctor addresses endometriosis myths and treatment options WTOC
Published: Feb. 18, 2026, 5:38 p.m.
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Solve PI3K Resistance - HIT Consultant
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Solve PI3K Resistance HIT Consultant
Published: Feb. 18, 2026, 5:03 p.m.
Southern Regional Press Institute marks 75 years at Savannah State University - WTOC
Southern Regional Press Institute marks 75 years at Savannah State University WTOC
Published: Feb. 18, 2026, 4:50 p.m.
Ballymun public meeting aims to break silence on PMDD and endometriosis - Dublin Live
Ballymun public meeting aims to break silence on PMDD and endometriosis Dublin Live
Published: Feb. 18, 2026, 4:28 p.m.
Behind the Harry Reich Award at EndoFound’s Annual Medical Conference - Endometriosis Foundation of America
Behind the Harry Reich Award at EndoFound’s Annual Medical Conference Endometriosis Foundation of America
Published: Feb. 18, 2026, 4:10 p.m.
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Priva - PharmiWeb.com
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Priva PharmiWeb.com
Published: Feb. 18, 2026, 4:05 p.m.
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement - PharmiWeb.com
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement PharmiWeb.com
Published: Feb. 18, 2026, 4:05 p.m.
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider
Published: Feb. 18, 2026, 3:28 p.m.
Link copied to clipboard!